However, the analysis revealed non-significant reduction in stroke with GLP-1 RA as compared with placebo (RR = 0.92; 95% confidence interval 0.74–1.13, p-value = 0.42, I2 = 0%) (Figure 12). Here, GLP1R is linked to stroke disorder.